VolitionRx Ltd
VNRX
15 hedge funds and large institutions have $10.6M invested in VolitionRx Ltd in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
162% more capital invested
Capital invested by funds: $4.05M → $10.6M (+$6.54M)
25% more funds holding
Funds holding: 12 → 15 (+3)
0.43% more ownership
Funds ownership: 0.24% → 0.68% (+0.43%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$6.05M |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$1.73M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$239K |
| 4 |
Goldman Sachs
New York
|
+$35.4K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$20.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$48K |
| 2 |
Morgan Stanley
New York
|
-$1.88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LIM
1
Lagoda Investment Management
New York
| $5.72M | +$6.05M | +80,617 | New |
|
|
SCA
2
Southpoint Capital Advisors
New York
| $2.84M | – | – | – |
|
|
KCM
3
Knoll Capital Management
Miami,
Florida
| $1.64M | +$1.73M | +23,077 | New |
|
|
4
Morgan Stanley
New York
| $108K | -$1.88K | -25 | -2% |
|
|
5
Goldman Sachs
New York
| $76K | +$35.4K | +472 | +79% |
|
|
GBA
6
Garrison Bradford & Associates
New York
| $55K | – | – | – |
|
|
VKH
7
Virtu KCG Holdings
New York
| $55K | +$20.1K | +268 | +53% |
|
8
Bank of New York Mellon
New York
| $36K | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $28K | +$19.6K | +261 | +202% |
|
10
Creative Planning
Overland Park,
Kansas
| $11K | – | – | – |
|
|
BFA
11
BlackRock Fund Advisors
San Francisco,
California
| $8K | +$1.73K | +23 | +27% |
|
|
BA
12
BlackRock Advisors
Wilmington,
Delaware
| $5K | – | – | – |
|
13
BlackRock
New York
| $4K | – | – | – |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| $1K | +$751 | +10 | New |
|
|
15
Geode Capital Management
Boston,
Massachusetts
| $226 | +$239K | +3,183 | New |
|
|
16
Millennium Management
New York
| – | -$48K | -536 | Closed |
|
VNRX Hedge Fund Activity: Q1 2016 in Review
15 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2016, worth a combined $10.6M — up 162% from $4.05M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new VNRX positions and 1 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Lagoda Investment Management, opening a new position worth an estimated $6.05M. The largest seller was Millennium Management, exiting entirely with an estimated $48K sold.
- 15 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2016, up from 12 in Q4 2015.
- Funds reported $10.6M of VolitionRx Ltd stock for Q1 2016, up 162% quarter-over-quarter.
- 4 funds opened new VolitionRx Ltd positions in Q1 2016 and 1 closed out, a net change of +3 holders.
- The largest VolitionRx Ltd buyer in Q1 2016 was Lagoda Investment Management, an estimated $6.05M added.
- The largest VolitionRx Ltd seller in Q1 2016 was Millennium Management, an estimated $48K sold.
Based on aggregated 13F filings for Q1 2016.